Globus Medical
GMED
481 hedge funds and large institutions have $6.73B invested in Globus Medical in 2025 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 197 increasing their positions, 149 reducing their positions, and 93 closing their positions.
2,135% more call options, than puts
Call options by funds: $34M | Put options by funds: $1.52M
32% more repeat investments, than reductions
Existing positions increased: 197 | Existing positions reduced: 149
6% less funds holding
Funds holding: 514 → 481 (-33)
11.71% less ownership
Funds ownership: 95.94% → 84.23% (-12%)
17% less funds holding in top 10
Funds holding in top 10: 18 → 15 (-3)
17% less capital invested
Capital invested by funds: $8.08B → $6.73B (-$1.35B)
29% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 93
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAP
Madison Avenue Partners
New York
|
+$111M |
| 2 |
Janus Henderson Group
London,
|
+$77.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$48.3M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$48.1M |
| 5 |
JP Morgan Chase
New York
|
+$46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$82.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$71M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$64M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$59.4M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$45.4M |
GMED Hedge Fund Activity: Q2 2025 in Review
481 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2025, worth a combined $6.73B — down 17% from $8.08B a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of GMED and 66 opened new positions — a net loss of 27 holders — while 149 trimmed existing stakes and 197 added.
The largest buyer was Madison Avenue Partners, opening a new position worth an estimated $111M. The largest seller was RTW Investments, exiting entirely with an estimated $82.3M sold.
- 481 institutional investors held Globus Medical (GMED) as of Q2 2025, down from 514 in Q1 2025.
- Funds reported $6.73B of Globus Medical stock for Q2 2025, down 17% quarter-over-quarter.
- 66 funds opened new Globus Medical positions in Q2 2025 and 93 closed out, a net change of -27 holders.
- The largest Globus Medical buyer in Q2 2025 was Madison Avenue Partners, an estimated $111M added.
- The largest Globus Medical seller in Q2 2025 was RTW Investments, an estimated $82.3M sold.
Based on aggregated 13F filings for Q2 2025.